Featured
TGA reins in breast cancer label
Australia's regulator has narrowed the patient population eligible for a breast cancer drug, after initially granting approval for a broader population than other major jurisdictions
Industry & Companies
Global boss: Why strong science isn't enough
Visting Australia this week to join a discussion about the need for policy and access to keep pace with innovation and scientific ambition
Regulatory & Reimbursement
World's biggest drug wins broad PBS listing
After a gruelling decade-long battle, a milestone PBS listing will see this oncology blockbuster made available to thousands of Australians living with certain advanced and metastatic cancers, including rare cancers
Regulatory & Reimbursement
Who's at the PBAC's next meeting?
PBAC will consider eight submissions with three companies laying the groundwork to secure a broad PBS listing recommendation for their immunotherapies
Latest
Spring blooms with fresh PBS listing
First-of-its-kind treatment in an area of unmet need scores a Spring PBS listing with the company's GM underlining the importance of innovative medicines for economic growth
Regulatory & Reimbursement
Company scores double PBS win
It's been quite the week for this company which announced a new General Manager on Friday and from tomorrow, two of its biggest drugs will be expanded
Regulatory & Reimbursement
Single-pill triple therapy wins TGA tick
The TGA has approved a new single-pill triple therapy for hypertension as Johnson & Johnson and Dr Falk Pharma expand their franchises
Featured
Company names new Aussie Country Leader
Almost six months after the departure of its Australian General Manager, this company has recruited the leader of a rival pharma as its next Aussie boss
Industry & Companies
Who's been crowned an Aussie Best Workplace?
Twelve health sector organisations, including three pharmas, have made the exclusive Best Workplaces in Australia 2026 list. Find out who made the cut
Leadership & People
ANZ GM lifts the lid on best workplace culture
Sandoz ANZ General Manager, Clint Holland, has pulled back the curtain on what makes the biosimilar & generics giant one of Australia’s Best Workplaces
Latest
Aussie patients name industry's best
At a gala ceremony in Melbourne last night, the Patients Choice Awards named those making a meaningful difference to the lives of patients
Jobs
Featured
King Kong of drugs a revenue booster
While debate over public funding of weight loss drugs continues, Sigma has reported "above the norm" sales growth driven by GLP-1s as patients load up on other products in store
Regulation & Legal
Double recognition for Aussie IP strategist
The head of a boutique law firm specialising in intellectual property relating to life sciences has been tapped as a top IP practitioner globally in two categories
Industry & Companies
Which pharma nets $1.4M... every 20 minutes?
An analysis of the world's top 200 companies reveals three pharmas are raking in seven-figures in net profit in under half an hour. Find out how fast your company makes US$1M
Jobs & Workplace
Long-timers jump to new companies
After more than a decade with the same company, these executives are moving on. Find out the latest appointments across industry
Industry & Companies
The pharma influencer adding emotion to data
From a standing ovation in Chicago to your screen in less than a day, a novel way to learn about the exciting conference sessions that are relevant to Australia
Regulatory & Reimbursement
Calls for PBS co-payment freeze
A peak industry body is calling on the Federal Government to freeze the general PBS co-pay price until 2030, naming the Top 5 medicines that have benefited from lower out-of-pocket costs for Australians
Jobs & Workplace
Salary rift emerges across pharma
There is a growing divide in Australian pharma between what companies want to pay and what workers are willing to accept with the fallout being felt across industry
Jobs & Workplace
Who will survive the next pharma downsize?
A brutal downsizing is coming to pharma with a broad range of roles simply ceasing to exist. Australian experts have revealed the skills and capabilities needed to survive
- Industry & Companies Aussie jobs to go after trial failure
- Leadership & People How Dolly quietly reshaped pharma
- Regulatory & Reimbursement First treatment funded through new pathway
- Industry & Companies Aussies team up with Japanese giant
- Regulatory & Reimbursement PBAC July meeting winners and losers
- Regulatory & Reimbursement PBAC says no to higher price for blockbuster
- Industry & Companies Roche muscles up with $3.2B weight loss play
- Regulatory & Reimbursement EU tick paves way for bumper payday
- Regulatory & Reimbursement Pfizer touts Australian results
- Other News AI tool builds synthetic patients and HCPs for pharma
